Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07462533 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Assess Efficacy of a Nanodiamond Periprocedural Skin Care Regimen for Ablative Resurfacing

StatusNot Yet Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated March 10, 2026 (before its estimated July 30, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
The primary objective of this study is to evaluate the efficacy and tolerability of Pavise Extracellular Matrix Restore (ECMR), compared with standard acute post-operative care, when used as the primary occlusive treatment immediately following ablative CO₂ and Er:YAG facial laser resurfacing to support wound healing.
Trial Details
NCT Number NCT07462533
Lead Sponsor Goldman, Butterwick, Fitzpatrick and Groff
Collaborators: Bai Biosciences
Conditions
(from sponsor)		 Skin Laxity
Related terms Cutis Laxa, Facies
Enrollment 8 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov